Unrelated donor BMT for CML.

被引：0
|
作者：
Dini, G
Lamparelli, T
Rondelli, R
Barbanti, M
Garbarino, L
Lanino, E
Guidi, S
Rosti, G
Alessandrino, EP
Locatelli, F
Marenco, P
Soligo, D
Di Bartolomeo, P
Aversa, F
La Nasa, G
Busca, A
Majolino, I
De Laurenzi, A
Bacigalupo, A
机构：
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
112
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [1] A decision analysis of unrelated donor transplantation (URD BMT) for CML.
    Lee, SJ
    Kuntz, KM
    Horowitz, MM
    McGlave, PB
    Hegland, J
    Kollman, C
    Weeks, JC
    Antin, JH
    BLOOD, 1996, 88 (10) : 1923 - 1923
  • [2] Interleukin-1 α genotype and outcome of unrelated donor BMT for CML.
    Mehta, PA
    Eapen, M
    Gandham, S
    Elliott, J
    Combs, M
    Wilke, T
    Aplenc, R
    MacMillan, ML
    Weisdorf, DJ
    Petersdorf, EW
    Klein, J
    Davies, SM
    BLOOD, 2005, 106 (11) : 582A - 582A
  • [3] MATCHED UNRELATED DONOR BMT FOR CML - COMPARISON OF EXVIVO AND INVIVO T-CELL DEPLETION
    CULLIS, JO
    CROSS, NP
    HUGHES, TP
    HALE, G
    WALDMANN, H
    GOLDMAN, JM
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 720 - 720
  • [4] Life-threatening immune pancytopenia after mud BMT for CML.
    Onida, F
    Pozzoli, E
    Tagliaferri, E
    Annaloro, C
    Della Volpe, A
    Deliliers, GL
    BONE MARROW TRANSPLANTATION, 1998, 21 : S33 - S33
  • [5] PROSPECTIVE EVALUATION OF UNRELATED DONOR BMT
    HOWS, J
    DOWNIE, T
    BRADLEY, B
    GORE, S
    HOWARD, M
    GLUCKMAN, E
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1015 - 1015
  • [6] UNRELATED DONOR BMT - THE ROLE OF HISTOCOMPATIBILITY
    BRADLEY, BA
    JEANNET, M
    BONE MARROW TRANSPLANTATION, 1993, 12 : S29 - S30
  • [7] Impact of recipient CMV status on outcome after T-depleted volunteer unrelated donor (VUD) transplantation for CML.
    Craddock, C
    Szydlo, R
    Ward, K
    Yong, A
    Brookes, P
    Kanfer, E
    Apperley, J
    Goldman, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 69 - 69
  • [8] Successful bone marrow engrafment after third BMT in accelerated phase CML.
    Manna, A
    Rizzo, C
    Cervellera, M
    Maggi, A
    Barcaglione, P
    Amurri, B
    Palazzo, G
    Mazza, P
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 1998, 21 : S81 - S81
  • [9] Impact of donor leucocyte infusions on outcome after T cell depleted volunteer unrelated donor (VUD) bone marrow transplantation in patients with CML.
    Craddock, C
    Dazzi, F
    Szydlo, R
    Cwynarski, K
    Olavarria, E
    Brookes, P
    Kanfer, E
    Apperley, J
    Goldman, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 32 - 32
  • [10] The cost-effectiveness of unrelated donor bone marrow transplantation (URD BMT) for chronic myelogenous leukemia (CML).
    Lee, SJ
    Anasetti, C
    Kuntz, KM
    Patten, J
    Antin, JH
    Weeks, JC
    BLOOD, 1997, 90 (10) : 472 - 472
12345